Tag: pharmaceuticals
-
Biomaterials Solutions Studied for Chronic Wounds
3 June 2016. A team of materials and medical scientists is investigating a new process of applying protein-based biomaterials to the healing of chronic wounds. The research led by materials scientists Millicent Sullivan and Kristi Kiick at University of Delaware in Newark is funded by a 4 year, $1.4 million grant from National Institute of…
-
Dispensing Device Shown to Boost Meds. Adherence
1 June 2016. A device that dispenses pills in prescribed dosages at specified times was shown in a user survey to improve adherence to medications for chronic conditions to almost 100 percent. The study by technology company Royal Phillips covered individuals in the Netherlands using the company’s Medido device for up to 1 year. The…
-
St. Jude Hospital to Test Nanotech Flu Virus Drugs
31 May 2016. A company developing anti-viral drugs delivered in nanoscale particles is partnering with scientists at St. Jude Children’s Research Hospital to test drug candidates to treat influenza. Financial details of the agreement between NanoViricides Inc. in Shelton, Connecticut and St. Jude hospital in Memphis were not disclosed. NanoViricides makes drugs that fight dangerous…
-
Boehringer, Inventiva Partner on Progressive Lung Disease
31 May 2016. Drug maker Boehringer Ingelheim and biopharmaceutical company Inventiva are collaborating on discovery of new treatments for idiopathic pulmonary fibrosis and related diseases causing fibrosis. The deal is expected to bring Inventiva, in Daix, France, as much as €170 million ($US 189 million), plus royalties on sales. Boehringer Ingelheim and Inventiva will jointly…
-
Another Chance to Get Serious on Drug Pricing
Stephen Ubl, president and CEO of Pharmaceutical Research and Manufacturers of America, or PhRMA, told a press and industry event in Washington, D.C. on Wednesday (25 May) that drug makers are eager to develop more individualized treatments for patients, but proposed regulations on drug pricing threaten that progress. Ubl also suggested, however, at the Annual…
-
Pricing Factors Proposed for Gene Therapies
Updated 27 May 2016. See Another Chance to Get Serious on Drug Pricing. A pediatric cancer specialist and venture capital executive argue for establishing a framework for pricing gene therapies to treat inherited and other diseases, before these treatments are approved by FDA. Stuart Orkin, a pediatric oncologist and hematologist at Dana-Farber Cancer Research Center…
-
Start-Up, Univ. Lab Partner on Computational Drug Discovery
25 May 2016. A two-year old company developing algorithms for drug discovery is collaborating with University of Chicago medical school to identify candidates to prevent atherosclerosis, or hardening of the arteries. Financial aspects of the agreement between twoXAR Inc. in Palo Alto, California and the lab of Yun Fang at University of Chicago were not…
-
New Process Boosts Injectable Drug Purity, Safety
20 May 2016. A team of engineers and chemists developed a process for enhancing the purity and safety of drugs given with injections by removing excess additives, while keeping the drugs easy to inject. Researchers from University at Buffalo in New York, led by biomedical engineering professor Jonathan Lovell, describe their process in yesterday’s issue…
-
Grid Computing Power Applied to Zika Research
Carolina Horta Andrade at Federal University of Goiás in Brazil, the lead researcher on the OpenZika project. (Ana Fortunato, IBM) 19 May 2016. A consortium in Brazil and the U.S. is employing distributed grid computing to provide processing power for research on prospective compounds for treating Zika virus infections. The OpenZika project is using World…
-
FDA Approves Trial Testing Stem Cells for Brain Injuries
Updated 10 June 2016. Gordie Howe died today at age 88. 18 May 2016. A company developing stem cell therapies says the U.S. Food and Drug Administration approved its application for a clinical trial testing stem cell treatments for traumatic brain injury. The intermediate-stage trial, sponsored by Stemedica Cell Technologies Inc. is part of a research…